PET and SPECT functional imaging in Parkinson's disease

Angelo Antonini, Roberta DeNotaris

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Neuroimaging studies of the dopaminergic system with positron emission tomography and single photon emission computed tomography radioligands are useful in the assessment of neuronal degeneration in Parkinson's disease. Abnormalities can be identified early in the disease process and used to monitor progression as well as the effect of treatment. Studies of dopamine receptors and brain metabolism can help identify those patients who have other Parkinsonian syndromes, such as multiple system atrophy, progressive sopranuclear palsy or diffuse Lewy body dementia. The current available diagnostic criteria for these disorders rely solely on the presence of signs and symptoms that may require months or years to become fully clinically manifest. Conversely, the use of neuroimaging techniques can significantly shorten the diagnostic process and prove a useful means to the neurologist in those cases presenting with uncertain clinical diagnosis.

Original languageEnglish
Pages (from-to)201-206
Number of pages6
JournalSleep Medicine
Volume5
Issue number2
DOIs
Publication statusPublished - Mar 2004

Fingerprint

Single-Photon Emission-Computed Tomography
Neuroimaging
Parkinson Disease
Multiple System Atrophy
Lewy Body Disease
Dopamine Receptors
Parkinsonian Disorders
Paralysis
Positron-Emission Tomography
Signs and Symptoms
Brain
Therapeutics
Neurologists

Keywords

  • Parkinson's disease
  • Positron emission tomography
  • Single photon emission computed tomography

ASJC Scopus subject areas

  • Ophthalmology
  • Pulmonary and Respiratory Medicine
  • Neurology
  • Dentistry(all)

Cite this

PET and SPECT functional imaging in Parkinson's disease. / Antonini, Angelo; DeNotaris, Roberta.

In: Sleep Medicine, Vol. 5, No. 2, 03.2004, p. 201-206.

Research output: Contribution to journalArticle

Antonini, Angelo ; DeNotaris, Roberta. / PET and SPECT functional imaging in Parkinson's disease. In: Sleep Medicine. 2004 ; Vol. 5, No. 2. pp. 201-206.
@article{9933038daf5c4a2fb8932b5c65725fb3,
title = "PET and SPECT functional imaging in Parkinson's disease",
abstract = "Neuroimaging studies of the dopaminergic system with positron emission tomography and single photon emission computed tomography radioligands are useful in the assessment of neuronal degeneration in Parkinson's disease. Abnormalities can be identified early in the disease process and used to monitor progression as well as the effect of treatment. Studies of dopamine receptors and brain metabolism can help identify those patients who have other Parkinsonian syndromes, such as multiple system atrophy, progressive sopranuclear palsy or diffuse Lewy body dementia. The current available diagnostic criteria for these disorders rely solely on the presence of signs and symptoms that may require months or years to become fully clinically manifest. Conversely, the use of neuroimaging techniques can significantly shorten the diagnostic process and prove a useful means to the neurologist in those cases presenting with uncertain clinical diagnosis.",
keywords = "Parkinson's disease, Positron emission tomography, Single photon emission computed tomography",
author = "Angelo Antonini and Roberta DeNotaris",
year = "2004",
month = "3",
doi = "10.1016/j.sleep.2003.10.013",
language = "English",
volume = "5",
pages = "201--206",
journal = "Sleep Medicine",
issn = "1389-9457",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - PET and SPECT functional imaging in Parkinson's disease

AU - Antonini, Angelo

AU - DeNotaris, Roberta

PY - 2004/3

Y1 - 2004/3

N2 - Neuroimaging studies of the dopaminergic system with positron emission tomography and single photon emission computed tomography radioligands are useful in the assessment of neuronal degeneration in Parkinson's disease. Abnormalities can be identified early in the disease process and used to monitor progression as well as the effect of treatment. Studies of dopamine receptors and brain metabolism can help identify those patients who have other Parkinsonian syndromes, such as multiple system atrophy, progressive sopranuclear palsy or diffuse Lewy body dementia. The current available diagnostic criteria for these disorders rely solely on the presence of signs and symptoms that may require months or years to become fully clinically manifest. Conversely, the use of neuroimaging techniques can significantly shorten the diagnostic process and prove a useful means to the neurologist in those cases presenting with uncertain clinical diagnosis.

AB - Neuroimaging studies of the dopaminergic system with positron emission tomography and single photon emission computed tomography radioligands are useful in the assessment of neuronal degeneration in Parkinson's disease. Abnormalities can be identified early in the disease process and used to monitor progression as well as the effect of treatment. Studies of dopamine receptors and brain metabolism can help identify those patients who have other Parkinsonian syndromes, such as multiple system atrophy, progressive sopranuclear palsy or diffuse Lewy body dementia. The current available diagnostic criteria for these disorders rely solely on the presence of signs and symptoms that may require months or years to become fully clinically manifest. Conversely, the use of neuroimaging techniques can significantly shorten the diagnostic process and prove a useful means to the neurologist in those cases presenting with uncertain clinical diagnosis.

KW - Parkinson's disease

KW - Positron emission tomography

KW - Single photon emission computed tomography

UR - http://www.scopus.com/inward/record.url?scp=1542681227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542681227&partnerID=8YFLogxK

U2 - 10.1016/j.sleep.2003.10.013

DO - 10.1016/j.sleep.2003.10.013

M3 - Article

VL - 5

SP - 201

EP - 206

JO - Sleep Medicine

JF - Sleep Medicine

SN - 1389-9457

IS - 2

ER -